Brachytherapy for Non-Metastatic Squamous Cell Carcinoma of the Buccal Mucosa: An Analysis of forty-five cases treated with permanent implants

Authors

  • Hitoshi Shibuya The Department of Radiology, Tokyo Medical and Dental University, Tokyo, Japan
  • Masamune Takeda The Department of Radiology, Tokyo Medical and Dental University, Tokyo, Japan
  • Satoru Matsumoto The Department of Radiology, Tokyo Medical and Dental University, Tokyo, Japan
  • Masao Hoshina The Department of Radiology, Tokyo Medical and Dental University, Tokyo, Japan
  • Manaljav Shagdarsuren The Department of Radiology, Tokyo Medical and Dental University, Tokyo, Japan
  • Soji Suzuki The Department of Radiology, Tokyo Medical and Dental University, Tokyo, Japan

DOI:

https://doi.org/10.3109/02841869309093604

Abstract

An analysis has been undertaken of 45 patients with non-metastatic squamous cell carcinoma of the buccal mucosa treated by permanent 198Au or 222Rn implants and in most cases supplementary external irradiation. Eight patients had T1, 30 had T2, and 7 T3 disease. Of the lesions 21 were located in the buccal mucosal surface, 14 in the retromolar region, and 10 in the bucco-alveolar sulci. Seven of the 45 (16%) died of the disease and the actuarial 5-year survival rate was 81%. No obvious differences were noted in survival rate between different stages of the disease or between different subsites of the primary lesion. There were 6 local recurrences occurring from 3 to 33 months after treatment, and only one of these was salvageable by further radiation therapy. Neck node metastasis occurred in 11 cases from 2 to 34 months after treatment, and 8 of these cases responded successfully to a radical neck dissection or radiotherapy.

Downloads

Download data is not yet available.

Downloads

Published

1993-01-01

How to Cite

Shibuya, H. ., Takeda, M. ., Matsumoto, S. ., Hoshina, M. ., Shagdarsuren, M. ., & Suzuki, S. . (1993). Brachytherapy for Non-Metastatic Squamous Cell Carcinoma of the Buccal Mucosa: An Analysis of forty-five cases treated with permanent implants. Acta Oncologica, 32(3), 327–330. https://doi.org/10.3109/02841869309093604